COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,673 Articles (22,913 medRxiv, 8,760 bioRxiv)

Most recent first Previous |  Page 1084: Articles 10831-10840  | Next

Infrared spectroscopy enables rapid, robust, portable COVID-19 saliva screening based on pathophysiological response to SARS-CoV-2
Kazmer, S., Hartel, G., Robinson, H., Richards, R. S., Yan, K., Van Hal, S. J., Chan, R., Hind, A., Bradley, D., Zieschang, F., Rawle, D. J., Le, T. T., Reid, D. W., Suhrbier, A., Hill, M. M.
10.1101/2021.12.22.21268265 — Posted: 2021-12-24
Saliva swabs are the preferred sample for Omicron detection
Marais, G. J. K., Hsiao, N.-y., Iranzadeh, A., Doolabh, D., Enoch, A., Chu, C. Y., Williamson, C., Brink, A., Hardie, D. R.
10.1101/2021.12.22.21268246 — Posted: 2021-12-24 Discussion: Onsite
Serum anti-Spike antibody titers before and after heterologous booster with mRNA-1273 SARS-CoV-2 vaccine following two doses of inactivated whole-virus CoronaVac vaccine
Sinto, R., Utomo, D., Suwarti, S., Nelwan, E. J., Surendra, H., Natasha, C., Fransiska, F., Theresia, D., Ranitria, A. F., Subekti, D., Nuraeni, N., Handayani, W., Rahardjani, M., Baird, J. K., Dunachie, S., Shankar, A. H., Hamers, R. L.
10.1101/2021.12.24.21268360 — Posted: 2021-12-24
Mitigating isolation: The use of rapid antigen testing to reduce the impact of self-isolation periods
Bays, D., Whiteley, T., Pindar, M., Taylor, J., Walker, B. F., Williams, H., Finnie, T. J. R., Gent, N.
10.1101/2021.12.23.21268326 — Posted: 2021-12-24 Discussion: Onsite
Diversity in antibody titer at an average of 87 days after the second dose of BNT162b2 mRNA coronavirus disease 2019 vaccine: data from a predominantly elderly population in a practice in Tokyo
Fuse-Nagase, Y., Nagase, M.
10.1101/2021.12.22.21268296 — Posted: 2021-12-24
Exploration of attitudes regarding uptake of COVID-19 vaccines among vaccine hesitant adults in the UK: A qualitative analysis.
Denford, S., Mowbray, F., Towler, L., Wehling, H., Lasseter, G., Amlot, R., Oliver, I., Yardley, L., Hickman, M.
10.1101/2021.12.23.21268325 — Posted: 2021-12-24
Monospecific and bispecific monoclonal SARS-CoV-2 neutralizing antibodies that maintain potency against B.1.617
Peng, L., Hu, Y., Mankowski, M., Ren, P., Chen, R., Wei, J., Zhao, M., Li, T., Tripler, T., Ye, L., Chow, R., Fang, Z., Wu, C., Dong, M., Cook, M., Wang, G., Clark, P., Nelson, B., Klein, D., Sutton, R., Diamond, M., Wilen, C., Xiong, Y., Chen, S.
10.1101/2021.12.21.473733 — Posted: 2021-12-24
COVID-19: Salient Aspects of Coronavirus Infection, Vaccines and Vaccination Testing and their Implications
Pasricha, P. K., Upadhayaya, A. K.
10.1101/2021.12.21.470882 — Posted: 2021-12-24
Rapid increase in Omicron infections in England during December 2021: REACT-1 study
Elliott, P., Bodinier, B., Eales, O., Wang, H., Haw, D., Elliott, J., Whitaker, M., Jonnerby, J., Tang, D., Walters, C. E., Atchinson, C., Diggle, P. J., Page, A. J., Trotter, A., Ashby, D., Barclay, W., Taylor, G., Ward, H., Darzi, A., Cooke, G., Chadeau-Hyam, M., Donnelly, C. A.
10.1101/2021.12.22.21268252 — Posted: 2021-12-24
Neutralization of SARS-CoV-2 Omicron pseudovirus by BNT162b2 vaccine-elicited human sera
Muik, A., Lui, B. G., Wallisch, A.-K., Bacher, M., Muehl, J., Reinholz, J., Ozhelvaci, O., Beckmann, N., de la Caridad Guimil Garcia, R., Poran, A., Shpyro, S., Cai, H., Yang, Q., Swanson, K. A., Tuereci, O., Sahin, U.
10.1101/2021.12.22.21268103 — Posted: 2021-12-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).